Atlas Trials

A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects

Clinical trial NCT02957448 · COMPLETED

Trial details

NCT number
NCT02957448
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Atherothrombotic Diseases
Start date
2016-11-01
Primary completion
2017-01-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.